We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$572B
AUM Growth
+$35.4B
Cap. Flow
+$12.6B
Cap. Flow %
2.21%
Top 10 Hldgs %
24.8%
Holding
13,475
New
1,572
Increased
5,247
Reduced
4,924
Closed
1,625

Sector Composition

Rank Sector Weight
1 Technology 1.85%
2 Consumer Discretionary 1.02%
3 Financials 0.76%
4 Communication Services 0.62%
5 Healthcare 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGF icon
12401
iShares Global Infrastructure ETF
IGF
$10.6B
-31,058
Closed -$1.49M
IGI
12402
Western Asset Investment Grade Defined Opportunity Trust
IGI
$95.6M
-13,571
Closed -$232K
IGIC icon
12403
International General Insurance
IGIC
$1.13B
-11,245
Closed -$189K
IHE icon
12404
CALL
iShares US Pharmaceuticals ETF
IHE
$1.75B
-6,200
Closed -$411K
IHF icon
12405
PUT
iShares US Healthcare Providers ETF
IHF
$1.23B
-18,800
Closed -$985K
IHY icon
12406
VanEck International High Yield Bond ETF
IHY
$43.5M
-17,008
Closed -$349K
IIIN icon
12407
CALL
Insteel Industries
IIIN
$581M
-38,700
Closed -$1.2M
IIIV icon
12408
i3 Verticals
IIIV
$304M
-53,672
Closed -$1.2M
IJH icon
12409
iShares Core S&P Mid-Cap ETF
IJH
$125B
-31,780
Closed -$1.92M
IMAX icon
12410
IMAX
IMAX
$2.99B
-78,114
Closed -$1.54M
IMNM icon
12411
CALL
Immunome
IMNM
$3.35B
-39,100
Closed -$473K
IMTB icon
12412
iShares Core 5-10 Year USD Bond ETF
IMTB
$276M
-6,776
Closed -$289K
IMRX icon
12413
Immuneering
IMRX
$341M
-88,756
Closed -$114K
INDE icon
12414
Matthews India Active ETF
INDE
$18.1M
-6,824
Closed -$209K
INDV icon
12415
PUT
Indivior Pharmaceuticals
INDV
$4.3B
-162,800
Closed -$2.62M
ING icon
12416
PUT
ING
ING
$100B
-33,800
Closed -$579K
INKM icon
12417
State Street Income Allocation ETF
INKM
$75.3M
-7,675
Closed -$235K
INMB icon
12418
INmune Bio
INMB
$67.2M
-42,772
Closed -$304K
INMB icon
12419
PUT
INmune Bio
INMB
$67.2M
-39,400
Closed -$348K
INQQ icon
12420
India Internet & Ecommerce ETF
INQQ
$46.4M
-14,668
Closed -$224K
INTF icon
12421
iShares International Equity Factor ETF
INTF
$3.78B
-41,253
Closed -$1.21M
INTR icon
12422
Inter&Co
INTR
$2.42B
-318,175
Closed -$2.2M
INTT icon
12423
inTEST
INTT
$145M
-16,825
Closed -$140K
INUV icon
12424
Inuvo
INUV
$11.6M
-1,897
Closed -$4.87K
INZY
12425
CALL
DELISTED
Inozyme Pharma
INZY
-16,100
Closed -$71.8K

Similar funds

Jeff Yass's Q3 2024 Portfolio in Review

As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
  • Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
  • Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
  • Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
  • Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
  • Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.